This company is no longer active
Origin Therapeutics Holdings Balance Sheet Health
Financial Health criteria checks 0/6
Insufficient data to determine the health of Origin Therapeutics Holdings
Key information
n/a
Debt to equity ratio
n/a
Debt
Interest coverage ratio | n/a |
Cash | n/a |
Equity | n/a |
Total liabilities | n/a |
Total assets | n/a |
Recent financial health updates
No updates
Recent updates
In this section we usually analyse Origin Therapeutics Holdings's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Origin Therapeutics Holdings has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.
Financial Position Analysis
Short Term Liabilities: Insufficient data to determine if U8B's short term assets cover its short term liabilities.
Long Term Liabilities: Insufficient data to determine if U8B's short term assets cover its long term liabilities.
Debt to Equity History and Analysis
Debt Level: Insufficient data to calculate U8B's net debt to equity ratio to determine if it is satisfactory.
Reducing Debt: Insufficient data to determine if U8B's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: Insufficient data to determine if U8B's debt is well covered by operating cash flow.
Interest Coverage: Insufficient data to determine if U8B's interest payments on its debt are well covered by EBIT.